1 terminated, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
Follow Centronuclear Myopathy: new trials by email Literature Review of Centronuclear Myopathy trials Research Report on Centronuclear Myopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies DYN101 - Centronuclear Myopathy | Phase 1 / Phase 2 | Withdrawn | Dynacure | 2024-01-01 | 2022-07-11 | |
| Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies DYN101 - Centronuclear Myopathy | Phase 1 / Phase 2 | Terminated | Dynacure | 14 | 2020-01-09 | 2023-06-27 |
Myopathies, Structural, Congenital (2) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1)
Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1)
Dynacure (2)
France (2) · Germany (2) · Belgium (1) · Denmark (1) · Netherlands (1) · United Kingdom (1)
Chris Freitag, MD (1) · N.C. Voermans, MD, PhD (1)